Tuberculosis (TB) Immunotherapy Phase 2 Study

NCT01380119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: V7
OTHER: placebo

Sponsor

Lisichansk Regional Tuberculosis Dispensary

Collaborators

[object Object]
[object Object]